175 related articles for article (PubMed ID: 16652146)
1. Sustained expression of Mect1-Maml2 is essential for tumor cell growth in salivary gland cancers carrying the t(11;19) translocation.
Komiya T; Park Y; Modi S; Coxon AB; Oh H; Kaye FJ
Oncogene; 2006 Oct; 25(45):6128-32. PubMed ID: 16652146
[TBL] [Abstract][Full Text] [Related]
2. Mect1-Maml2 fusion oncogene linked to the aberrant activation of cyclic AMP/CREB regulated genes.
Coxon A; Rozenblum E; Park YS; Joshi N; Tsurutani J; Dennis PA; Kirsch IR; Kaye FJ
Cancer Res; 2005 Aug; 65(16):7137-44. PubMed ID: 16103063
[TBL] [Abstract][Full Text] [Related]
3. A reappraisal of the MECT1/MAML2 translocation in salivary mucoepidermoid carcinomas.
Seethala RR; Dacic S; Cieply K; Kelly LM; Nikiforova MN
Am J Surg Pathol; 2010 Aug; 34(8):1106-21. PubMed ID: 20588178
[TBL] [Abstract][Full Text] [Related]
4. MECT1-MAML2 fusion transcript defines a favorable subset of mucoepidermoid carcinoma.
Okabe M; Miyabe S; Nagatsuka H; Terada A; Hanai N; Yokoi M; Shimozato K; Eimoto T; Nakamura S; Nagai N; Hasegawa Y; Inagaki H
Clin Cancer Res; 2006 Jul; 12(13):3902-7. PubMed ID: 16818685
[TBL] [Abstract][Full Text] [Related]
5. Aberrantly activated AREG-EGFR signaling is required for the growth and survival of CRTC1-MAML2 fusion-positive mucoepidermoid carcinoma cells.
Chen Z; Chen J; Gu Y; Hu C; Li JL; Lin S; Shen H; Cao C; Gao R; Li J; Ha PK; Kaye FJ; Griffin JD; Wu L
Oncogene; 2014 Jul; 33(29):3869-77. PubMed ID: 23975434
[TBL] [Abstract][Full Text] [Related]
6. Chromosomal imbalances, 11q21 rearrangement and MECT1-MAML2 fusion transcript in mucoepidermoid carcinomas of the salivary gland.
Verdorfer I; Fehr A; Bullerdiek J; Scholz N; Brunner A; Krugmann J; Hager M; Haufe H; Mikuz G; Scholtz A
Oncol Rep; 2009 Aug; 22(2):305-11. PubMed ID: 19578770
[TBL] [Abstract][Full Text] [Related]
7. A study of MECT1-MAML2 in mucoepidermoid carcinoma and Warthin's tumor of salivary glands.
Martins C; Cavaco B; Tonon G; Kaye FJ; Soares J; Fonseca I
J Mol Diagn; 2004 Aug; 6(3):205-10. PubMed ID: 15269296
[TBL] [Abstract][Full Text] [Related]
8. 11q21 rearrangement is a frequent and highly specific genetic alteration in mucoepidermoid carcinoma.
Clauditz TS; Gontarewicz A; Wang CJ; Münscher A; Laban S; Tsourlakis MC; Knecht R; Sauter G; Wilczak W
Diagn Mol Pathol; 2012 Sep; 21(3):134-7. PubMed ID: 22847156
[TBL] [Abstract][Full Text] [Related]
9. Molecular classification of mucoepidermoid carcinomas-prognostic significance of the MECT1-MAML2 fusion oncogene.
Behboudi A; Enlund F; Winnes M; Andrén Y; Nordkvist A; Leivo I; Flaberg E; Szekely L; Mäkitie A; Grenman R; Mark J; Stenman G
Genes Chromosomes Cancer; 2006 May; 45(5):470-81. PubMed ID: 16444749
[TBL] [Abstract][Full Text] [Related]
10. t(11;19) translocation and CRTC1-MAML2 fusion oncogene in mucoepidermoid carcinoma.
O'Neill ID
Oral Oncol; 2009 Jan; 45(1):2-9. PubMed ID: 18486532
[TBL] [Abstract][Full Text] [Related]
11. CRTC1-MAML2 fusion-induced lncRNA LINC00473 expression maintains the growth and survival of human mucoepidermoid carcinoma cells.
Chen Z; Lin S; Li JL; Ni W; Guo R; Lu J; Kaye FJ; Wu L
Oncogene; 2018 Apr; 37(14):1885-1895. PubMed ID: 29353885
[TBL] [Abstract][Full Text] [Related]
12. Transforming activity of MECT1-MAML2 fusion oncoprotein is mediated by constitutive CREB activation.
Wu L; Liu J; Gao P; Nakamura M; Cao Y; Shen H; Griffin JD
EMBO J; 2005 Jul; 24(13):2391-402. PubMed ID: 15961999
[TBL] [Abstract][Full Text] [Related]
13. t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway.
Tonon G; Modi S; Wu L; Kubo A; Coxon AB; Komiya T; O'Neil K; Stover K; El-Naggar A; Griffin JD; Kirsch IR; Kaye FJ
Nat Genet; 2003 Feb; 33(2):208-13. PubMed ID: 12539049
[TBL] [Abstract][Full Text] [Related]
14. Reevaluation of MAML2 fusion-negative mucoepidermoid carcinoma: a subgroup being actually hyalinizing clear cell carcinoma of the salivary gland with EWSR1 translocation.
Hsieh MS; Wang H; Lee YH; Ko JY; Chang YL
Hum Pathol; 2017 Mar; 61():9-18. PubMed ID: 27769871
[TBL] [Abstract][Full Text] [Related]
15. CRTC1 rearrangements in the absence of t(11;19) in primary cutaneous mucoepidermoid carcinoma.
Lennerz JK; Perry A; Dehner LP; Pfeifer JD; Lind AC
Br J Dermatol; 2009 Oct; 161(4):925-9. PubMed ID: 19438452
[TBL] [Abstract][Full Text] [Related]
16. Gene expression profiling analysis of CRTC1-MAML2 fusion oncogene-induced transcriptional program in human mucoepidermoid carcinoma cells.
Chen J; Li JL; Chen Z; Griffin JD; Wu L
BMC Cancer; 2015 Oct; 15():803. PubMed ID: 26503699
[TBL] [Abstract][Full Text] [Related]
17. Molecular heterogeneity in mucoepidermoid carcinoma: conceptual and practical implications.
Bell D; El-Naggar AK
Head Neck Pathol; 2013 Mar; 7(1):23-7. PubMed ID: 23459841
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of p27Kip1, Ki-67, and CRTC1-MAML2 fusion transcript in mucoepidermoid carcinoma: a molecular and clinicopathologic study of 101 cases.
Miyabe S; Okabe M; Nagatsuka H; Hasegawa Y; Inagaki A; Ijichi K; Nagai N; Eimoto T; Yokoi M; Shimozato K; Inagaki H
J Oral Maxillofac Surg; 2009 Jul; 67(7):1432-41. PubMed ID: 19531414
[TBL] [Abstract][Full Text] [Related]
19. CRTC1-MAML2 and CRTC3-MAML2 fusions were not detected in metaplastic Warthin tumor and metaplastic pleomorphic adenoma of salivary glands.
Skálová A; Vanecek T; Simpson RH; Vazmitsel MA; Majewska H; Mukensnabl P; Hauer L; Andrle P; Hosticka L; Grossmann P; Michal M
Am J Surg Pathol; 2013 Nov; 37(11):1743-50. PubMed ID: 24121173
[TBL] [Abstract][Full Text] [Related]
20. A closer look at Warthin tumors and the t(11;19).
Fehr A; Röser K; Belge G; Löning T; Bullerdiek J
Cancer Genet Cytogenet; 2008 Jan; 180(2):135-9. PubMed ID: 18206539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
